Transcriptional Targeting in Cancer Gene Therapy

Por Robson, Tracy, Hirst, David G.
Publicado em 2003

The contribution of N(2)O(3) to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation

Por Ali, Ahlam A., Coulter, Jonathan A., Ogle, Claire H., Migaud, Marie M., Hirst, David G., Robson, Tracy, McCarthy, Helen O.
Publicado em 2013

RALA-mediated delivery of FKBPL nucleic acid therapeutics

Por Bennett, Rachel, Yakkundi, Anita, McKeen, Hayley D, McClements, Lana, McKeogh, Thomas J, McCrudden, Cian M, Arthur, Kenneth, Robson, Tracy, McCarthy, Helen O
Publicado no Nanomedicine (Lond) (2015)

Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment

Por McCrudden, Cian M., McBride, John W., McCaffrey, Joanne, Ali, Ahlam A., Dunne, Nicholas J., Kett, Vicky L., Coulter, Jonathan A., Robson, Tracy, McCarthy, Helen O.
Publicado no Mol Ther Nucleic Acids (2017)

The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway

Por Yakkundi, Anita, McCallum, Lynn, O’Kane, Anthony, Dyer, Hayder, Worthington, Jenny, McKeen, Hayley D., McClements, Lana, Elliott, Christopher, McCarthy, Helen O., Hirst, David G., Robson, Tracy
Publicado em 2013

Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?

Por Ali, Majid, Telfer, Brian A, McCrudden, Cian, O’Rourke, Martin, Thomas, Huw D, Kamjoo, Marzieh, Kyle, Suzanne, Robson, Tracy, Shaw, Chris, Hirst, David G., Curtin, Nicola J, Williams, Kaye J
Publicado em 2009

Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study

Por Sunnotel, Olaf, Hiripi, Laszlo, Lagan, Kevin, McDaid, Jennifer R, De León, Johanny M, Miyagawa, Yasushi, Crowe, Hannah, Kaluskar, Soniya, Ward, Michael, Scullion, Catherine, Campbell, Alan, Downes, CS, Hirst, David, Barton, David, Mocanu, Edgar, Tsujimura, Akira, Cox, Marc B, Robson, Tracy, Walsh, Colum P
Publicado em 2010

FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism

Por Valentine, Andrea, O’Rourke, Martin, Yakkundi, Anita, Worthington, Jenny, Hookham, Michelle, Bicknell, Roy, McCarthy, Helen O., McClelland, Keeva, McCallum, Lynn, Dyer, Hayder, McKeen, Hayley, Waugh, David, Roberts, Jennifer, McGregor, Joanne, Cotton, Graham, James, Iain, Harrison, Timothy, Hirst, David G., Robson, Tracy
Publicado em 2011

FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis

Por Yakkundi, Anita, Bennett, Rachel, Hernández-Negrete, Ivette, Delalande, Jean-Marie, Hanna, Mary, Lyubomska, Oksana, Arthur, Kenneth, Short, Amy, McKeen, Hayley, Nelson, Laura, McCrudden, Cian M., McNally, Ross, McClements, Lana, McCarthy, Helen O., Burns, Alan J., Bicknell, Roy, Kissenpfennig, Adrien, Robson, Tracy
Publicado no Arterioscler Thromb Vasc Biol (2015)

PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy

Por Armstrong, Chris W.D., Maxwell, Pamela J., Ong, Chee Wee, Redmond, Kelly M., McCann, Christopher, Neisen, Jessica, Ward, George A., Chessari, Gianni, Johnson, Christopher, Crawford, Nyree T., LaBonte, Melissa J., Prise, Kevin M., Robson, Tracy, Salto-Tellez, Manuel, Longley, Daniel B., Waugh, David J.J.
Publicado no Oncotarget (2016)

Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself

Por McCrudden, Cian M., O’Rourke, Martin G., Cherry, Kim E., Yuen, Hiu-Fung, O’Rourke, Declan, Babur, Muhammad, Telfer, Brian A., Thomas, Huw D., Keane, Patrick, Nambirajan, Thiagarajan, Hagan, Chris, O’Sullivan, Joe M., Shaw, Chris, Williams, Kaye J., Curtin, Nicola J., Hirst, David G., Robson, Tracy
Publicado no PLoS One (2015)

Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

Por Lawler, Mark, Gavin, Anna, Salto‐Tellez, Manuel, Kennedy, Richard D., Van Schaeybroeck, Sandra, Wilson, Richard H., Harkin, Denis Paul, Grayson, Margaret, Boyd, Ruth E., Hamilton, Peter W., McArt, Darragh G., James, Jacqueline, Robson, Tracy, Ladner, Robert D., Prise, Kevin M., O'Sullivan, Joe M., Harrison, Timothy, Murray, Liam, Johnston, Patrick G., Waugh, David J.
Publicado no Cancer (2015)

FKBPL: a marker of good prognosis in breast cancer

Por Nelson, Laura, McKeen, Hayley D., Marshall, Andrea, Mulrane, Laoighse, Starczynski, Jane, Storr, Sarah J., Lanigan, Fiona, Byrne, Christopher, Arthur, Ken, Hegarty, Shauna, Ali, Ahlam Abdunnabi, Furlong, Fiona, McCarthy, Helen O., Ellis, Ian O., Green, Andrew R., Rakha, Emad, Young, Leonie, Kunkler, Ian, Thomas, Jeremy, Jack, Wilma, Cameron, David, Jirström, Karin, Yakkundi, Anita, McClements, Lana, Martin, Stewart G., Gallagher, William M., Dunn, Janet, Bartlett, John, O’Connor, Darran, Robson, Tracy
Publicado no Oncotarget (2015)